MedPath

Effect of an Experimental Gel Containing Copaiba Oil-resin in the Control of Dentin Hypersensitivity

Not Applicable
Completed
Conditions
Pain
Dentin Sensitivity
Dentin Desensitizing Agents
Registration Number
NCT06872749
Lead Sponsor
Universidade Federal do Para
Brief Summary

This randomized, single-blind, placebo-controlled clinical trial aims to clinically evaluate the effect of an experimental gel containing copaiba oleo-resin in the control of dentin hypersensitivity (DH) in non-carious cervical lesions (NCCL). Seventy-five hypersensitive teeth will be selected into three groups (N=25) and approved in three treatment sessions. The groups will be: GROUP P= water-soluble placebo gel without active ingredient; GROUP KF2: Potassium nitrate 5% + Sodium fluoride 2%; GROUP GC: Gel containing copaiba oleo-resin. A visual analogue scale (VAS) will be used to compare the DH after tactile stimulation with an exploratory probe and evaporative stimulation with air jets. The DH assessments will be performed at four times: baseline, after 1 week, 15 days and 30 days after the beginning of treatment.

Detailed Description

The sequence of application of the gels, whether active or placebo, will be as follows:

A professional prophylaxis will be performed using a rubber cup on the dental elements. The corresponding gel for each group will be applied with the aid of a micro-applicator and will remain undisturbed on the surface for 10 minutes. After the gel application time has elapsed, and while it is still on the teeth, the product will be rubbed with a micro-applicator using circular and intermittent movements. Subsequently, the gel will be removed with cotton and abundant water.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
75
Inclusion Criteria
  • hypersensitive areas on the vestibular surface of the teeth with exposed cervical dentin up to 1 mm deep and/or class I gingival recession according to the Miller classification;
  • individuals who have at least two hypersensitive teeth
  • periodontal health,
  • good general physical health;
  • willingness to participate in the research by providing written informed consent;
  • no eating disorders or very acidic diets
Exclusion Criteria
  • presence of restorations;
  • presence of dental caries and periodontal pockets;
  • ongoing treatment with antibiotics and/or anti-inflammatory and/or analgesic drugs;
  • professional desensitizing treatment received three months prior to the study;
  • pregnancy or lactation; systemic diseases;
  • pulpitis;
  • use of orthodontic appliances or dental prostheses that may interfere with the assessment of hypersensitivity

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
sensitivity assessment30 days

Evaluation of hypersensitivity in teeth with non-carious cervical lesions. Patients will be instructed to complete a form to record tooth sensitivity before the application of the gels. An evaluation will be performed at baseline, 7 days, 15 days and 30 days, based on their individual perception of pain. The evaluation form will consist of a visual analogue scale (VAS). This scale consists of a 10 cm horizontal line with points of 0 and 10 at its ends, where 0 means no sensitivity and 10 means severe tooth sensitivity. The patient will be instructed to draw a vertical line along the horizontal line of the scale, recording the intensity of tooth sensitivity. So that the distance in millimeters from the zero end can later be measured with the aid of a millimeter ruler, thus obtaining the intensity level of the patient's back.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Universidade Federal Do Para

🇧🇷

Belém, Pará, Brazil

© Copyright 2025. All Rights Reserved by MedPath